NeuBase Therapeutics Inc

NBSE

$3.97

-51.9% (1 year change)

Market Cap

$130 Million

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$3.26 - $12.89

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

0.0x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $130 Million
Enterprise Value -
Dividend Yield $0.00 (0.0%)
1 Year Return -51.9%
52-Week High $12.89
52-Week Low $3.26
Beta 1.29
Outstanding Shares 32.7 Million
Avg 30 Day Volume 109 Thousand

Valuation

P/E Ratio 0.0
PEG -
Earnings per Share $0.00
Price to Sales Ratio -
Price to Book Ratio -
Revenue to Enterprise Value -
EBIT to Enterprise Value -
Total Debt to Enterprise Value -
Debt to Equity -

Profitability

Revenue -
Gross Profit -
EBIT -
Net Income -
Profit Margin -
Quarterly Earnings Growth (YoY) -
Return on Equity -
Return on Assets -
Return on Invested Capital -

News

NeuBase Therapeutics Appoints Anthony Rossomando, Ph.D. as Chief Technology Officer

NeuBase Therapeutics Appoints Anthony Rossomando, Ph.D. as Chief Technology Officer

PITTSBURGH, Sept. 14, 2021 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (NeuBase or the Company), a biotechnology platform company Drugging the Genome to address disease at the bas...

Intrado Digital Media Intrado Digital Media, 11 days ago
NeuBase Therapeutics reports Q1 results

NeuBase Therapeutics reports Q1 results

No summary available.

Seeking Alpha Seeking Alpha, 4 months ago
David Einhorn — Notorious Tesla Short Seller — Just Had His Best Quarter Ever

David Einhorn — Notorious Tesla Short Seller — Just Had His Best Quarter Ever

Greenlight Capital hedge fund manager and notorious value investor David Einhorn just released his annual letter to investors, which revealed a record quarter for Einhorn to close out a difficult 2...

Benzinga Benzinga, 8 months ago